Abstract
Introduction
The Metabolomics Quality Assurance and Quality Control Consortium (mQACC) organized a workshop during the Metabolomics 2022 conference.
Objectives
The goal of the workshop was to disseminate recent findings from mQACC community-engagement efforts and to solicit feedback about a living guidance document of QA/QC best practices for untargeted LC–MS metabolomics.
Methods
Four QC-related topics were presented.
Results
During the discussion, participants expressed the need for detailed guidance on a broad range of QA/QC-related topics accompanied by use-cases.
Conclusions
Ongoing efforts will continue to identify, catalog, harmonize, and disseminate QA/QC best practices, including outreach activities, to establish and continually update QA/QC guidelines.
Data availability
All data are included in the manuscript.
Code availability
Not applicable.
References
Beger, R. D., Dunn, W. B., Bandukwala, A., Bethan, B., Broadhurst, D., Clish, C. B., et al. (2019). Towards quality assurance and quality control in untargeted metabolomics studies. Metabolomics: Official Journal of the Metabolomic Society, 15(1), 4. https://doi.org/10.1007/s11306-018-1460-7
Broadhurst, D., Goodacre, R., Reinke, S. N., Kuligowski, J., Wilson, I. D., Lewis, M. R., & Dunn, W. B. (2018). Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics: Official Journal of the Metabolomic Society, 14(6), 72. https://doi.org/10.1007/s11306-018-1367-3
Croixmarie, V., Umbdenstock, T., Cloarec, O., Moreau, A., Pascussi, J.-M., BoursierNeyret, C., & Walther, B. (2009). Integrated comparison of drug-related and drug-induced ultra performance liquid chromatography/mass spectrometry metabonomic profiles using human hepatocyte cultures. Analytical Chemistry, 81, 6061–6069. https://doi.org/10.1021/ac900333e
European Medicines Agency. (2018). Bioanalytical method validation - Scientific guideline. European Medicines Agency. Retrieve from 13 February 2023 https://www.ema.europa.eu/en/bioanalytical-method-validation-scientific-guideline
Evans, A. M., O’Donovan, C., Playdon, M., Beecher, C., Beger, R. D., Bowden, J. A., et al. (2020). Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners. Metabolomics: Official Journal of the Metabolomic Society, 16(10), 113. https://doi.org/10.1007/s11306-020-01728-5
Food and Drug Administration (2018). Bioanalytical Method Validation, Guidance for Industry US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), and Center for Veterinary Medicine (CVM), Retrieve from 13 February 2023 https://www.fda.gov/media/70858/download
Kirwan, J. A., Gika, H., Beger, R. D., Bearden, D., Dunn, W. B., Goodacre, R., et al. (2022). Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management. Metabolomics: Official Journal of the Metabolomic Society, 18(9), 70. https://doi.org/10.1007/s11306-022-01926-3
Lewis, M., Pearce, J. T. M., Spagou, K., Green, M., Dona, A. C., Yuen, A. H. Y., et al. (2016). Development and application of ultra-performance liquid chromatography-TOF MS for precision large scale urinary metabolic phenotyping. Analytical Chemistry, 88(18), 9004–9013. https://doi.org/10.1021/acs.analchem.6b01481
Martínez-Sena, T., Luongo, G., Sanjuan-Herráez, D., Castell, J. V., Vento, M., Quintás, G., & Kuligowski, J. (2019). Monitoring of system conditioning after blank injections in untargeted UPLC-MS metabolomics analysis. Scientific Reports, 9(1), 1–9. https://doi.org/10.1038/s41598-019-46371-w
Viant, M. R., Ebbels, T. M. D., Beger, R. D., Ekman, D. R., Epps, D. J. T., Kamp, H., et al. (2019). Use cases, best practice and reporting standards for metabolomics in regulatory toxicology. Nature Communications, 10(1), 3041. https://doi.org/10.1038/s41467-019-10900-y
Acknowledgements
The authors would like to thank the Metabolomics Society and the Metabolomics 2022 scientific organising committee for the opportunity to host the workshop.
Funding
The work presented did not receive any funding. JK acknowledges financial support received from Carlos III Health Institute (Spain) (grant number CPII21/00003). DV acknowledges financial support from Fonds de Recherche du Quebec—Sante (FRQS) (Chercheur Boursier Junior 2 grant 312947).
Author information
Authors and Affiliations
Consortia
Contributions
All authors contributed equally to the organization of the workshop. The manuscript draft was prepared by JK and WBD and all authors commented and edited the manuscript and approved submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Disclaimer
This article reflects the views of the author(s) and does not necessarily represent the views or policies of the U.S. Environmental Protection Agency (EPA) nor the National Institutes of Health (NIH). Certain commercial equipment, instruments, trade names, products or materials are identified in this paper in order to specify the experimental procedure adequately. Such identification is not intended to imply or convey and should not be interpreted as conveying official approval, recommendation or endorsement by the National Institute of Standards and Technology, the EPA, or the NIH, nor is it intended to imply that the materials or equipment identified are necessarily the best available for the purpose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dunn, W.B., Kuligowski, J., Lewis, M. et al. Metabolomics 2022 workshop report: state of QA/QC best practices in LC–MS-based untargeted metabolomics, informed through mQACC community engagement initiatives. Metabolomics 19, 93 (2023). https://doi.org/10.1007/s11306-023-02060-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11306-023-02060-4